Clinical Trial Update: RESynchronisation in Patients With Heart Failure and a Normal QRS Duration [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating resynchronisation therapy in patients with heart failure and a normal QRS duration. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Heart of England NHS Trust | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED